| Style | Citing Format |
|---|---|
| MLA | Saberi S, et al.. "Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients." JBJS Open Access, vol. 11, no. 3, 2026, pp. -. |
| APA | Saberi S, Talebi A, Naghizadeh H, Bahmani M, Jahanbin H, Khabiri S S (2026). Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients. JBJS Open Access, 11(3), -. |
| Chicago | Saberi S, Talebi A, Naghizadeh H, Bahmani M, Jahanbin H, Khabiri S S. "Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients." JBJS Open Access 11, no. 3 (2026): -. |
| Harvard | Saberi S et al. (2026) 'Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients', JBJS Open Access, 11(3), pp. -. |
| Vancouver | Saberi S, Talebi A, Naghizadeh H, Bahmani M, Jahanbin H, Khabiri S S. Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients. JBJS Open Access. 2026;11(3):-. |
| BibTex | @article{ author = {Saberi S and Talebi A and Naghizadeh H and Bahmani M and Jahanbin H and Khabiri S S}, title = {Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients}, journal = {JBJS Open Access}, volume = {11}, number = {3}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Saberi S AU - Talebi A AU - Naghizadeh H AU - Bahmani M AU - Jahanbin H AU - Khabiri S S TI - Predicting Interval Pulmonary Metastasis in Extremity Soft Tissue Sarcoma Treated With Preoperative Radiotherapy: A Risk-Stratified Cohort Study of 378 Patients JO - JBJS Open Access VL - 11 IS - 3 SP - EP - PY - 2026 ER - |